Published in Lancet on August 13, 2014
Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol (2015) 4.87
Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol (2014) 4.00
Sex-age-specific association of body mass index with all-cause mortality among 12.8 million Korean adults: a prospective cohort study. Int J Epidemiol (2015) 2.30
Weight cycling and cancer incidence in a large prospective US cohort. Am J Epidemiol (2015) 2.00
Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care. PLoS Med (2015) 1.50
Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet (2017) 1.44
The obesity and cancer link. Ann Oncol (2014) 1.41
Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer (2015) 1.32
Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci (2014) 1.08
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. Nat Genet (2016) 1.01
Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis. Cancer Prev Res (Phila) (2014) 0.91
HIF3A DNA Methylation Is Associated with Childhood Obesity and ALT. PLoS One (2015) 0.90
Low risk of solid tumors in persons with Down syndrome. Genet Med (2016) 0.88
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. PLoS Med (2016) 0.87
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. Oncotarget (2015) 0.86
Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies. PLoS One (2015) 0.85
Real-world data in the United Kingdom: opportunities and challenges. BMC Med (2016) 0.83
Why does obesity promote cancer? Epidemiology, biology, and open questions. Ecancermedicalscience (2015) 0.83
Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men. PLoS One (2015) 0.82
Leptin-Induced JAK/STAT Signaling and Cancer Growth. Vaccines (Basel) (2016) 0.82
Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight. Nutrients (2014) 0.82
Sensitivity and Specificity Improvement in Abdominal Obesity Diagnosis Using Cluster Analysis during Waist Circumference Cut-Off Point Selection. J Diabetes Res (2015) 0.82
Leptin and Adiponectin Modulate the Self-renewal of Normal Human Breast Epithelial Stem Cells. Cancer Prev Res (Phila) (2015) 0.82
Evaluation of effect of body mass index and weight loss on survival of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Radiat Oncol (2015) 0.82
Obesity risk in rural, urban and rural-to-urban migrants: prospective results of the PERU MIGRANT study. Int J Obes (Lond) (2015) 0.81
Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. Int J Cancer (2016) 0.81
Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink. PLoS Med (2016) 0.81
Obesity and weight loss could alter the properties of adipose stem cells? World J Stem Cells (2015) 0.81
Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States. Eur J Epidemiol (2016) 0.79
Fat Intake Is Not Linked to Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis. PLoS One (2015) 0.79
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications. Oncologist (2016) 0.79
Cross-Sectional Associations between Body Mass Index and Hyperlipidemia among Adults in Northeastern China. Int J Environ Res Public Health (2016) 0.79
Prospective cohort study of general and central obesity, weight change trajectory and risk of major cancers among Chinese women. Int J Cancer (2016) 0.78
High body mass index and cancer risk-a Mendelian randomisation study. Eur J Epidemiol (2016) 0.78
Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes Control (2016) 0.78
Childhood body mass index and height and risk of histologic subtypes of endometrial cancer. Int J Obes (Lond) (2016) 0.78
Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma. Int J Clin Exp Med (2015) 0.78
2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget (2017) 0.77
Overweight and obesity are linked to 10 common cancers and more than 12,000 UK cases. BMJ (2014) 0.77
Chromatin Modifications Associated With Diabetes and Obesity. Arterioscler Thromb Vasc Biol (2015) 0.77
The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study. Sci Rep (2016) 0.77
Obesity: a certain and avoidable cause of cancer. Lancet (2014) 0.77
Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe. Br J Cancer (2017) 0.76
Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women's Health Initiative: A Longitudinal Study from the United States. PLoS Med (2016) 0.76
Preventive obesity agent montmorillonite adsorbs dietary lipids and enhances lipid excretion from the digestive tract. Sci Rep (2016) 0.76
Gender Differences in Adipocyte Metabolism and Liver Cancer Progression. Front Genet (2016) 0.76
Anthropometry and the Risk of Lung Cancer in EPIC. Am J Epidemiol (2016) 0.76
The feasibility and effectiveness of high-intensity boxing training versus moderate-intensity brisk walking in adults with abdominal obesity: a pilot study. BMC Sports Sci Med Rehabil (2015) 0.76
Association of insulin resistance with breast, ovarian, endometrial and cervical cancers in non-diabetic women. Am J Cancer Res (2016) 0.75
Visceral adipose tissue measured by computed tomography and high-grade prostate cancer after radical prostatectomy. Int J Obes (Lond) (2015) 0.75
Panx3 links body mass index and tumorigenesis in a genetically heterogeneous mouse model of carcinogen-induced cancer. Genome Med (2016) 0.75
Evaluation of Breast Lipid Composition in Patients with Benign Tissue and Cancer by Using Multiple Gradient-Echo MR Imaging. Radiology (2016) 0.75
Weight Loss and Mortality in Overweight and Obese Cancer Survivors: A Systematic Review. PLoS One (2017) 0.75
Body Mass Index Can Increase the Risk of Gallbladder Cancer: A Meta-Analysis of 14 Cohort Studies. Med Sci Monit Basic Res (2016) 0.75
Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy. PLoS One (2015) 0.75
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study. PLoS One (2017) 0.75
Effect of comedication of bupropion and other antidepressants on body mass index. Ther Adv Psychopharmacol (2015) 0.75
Dietary sugar intake increases liver tumor incidence in female mice. Sci Rep (2016) 0.75
Bariatric Surgery Prior to Index Screening Colonoscopy Is Associated With a Decreased Rate of Colorectal Adenomas in Obese Individuals. Clin Transl Gastroenterol (2017) 0.75
Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma. Oncotarget (2017) 0.75
Obesity and Women's Health. Facts Views Vis Obgyn (2014) 0.75
Cholesterol Synthetase DHCR24 Induced by Insulin Aggravates Cancer Invasion and Progesterone Resistance in Endometrial Carcinoma. Sci Rep (2017) 0.75
Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy. Mol Clin Oncol (2015) 0.75
Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England. PLoS One (2017) 0.75
Proportion of cancer in a Middle eastern country attributable to established risk factors. BMC Cancer (2017) 0.75
[Obesity and cancer]. Soins (2014) 0.75
Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy. Gynecol Oncol Res Pract (2016) 0.75
Self-Expansion is Associated with Better Adherence and Obesity Treatment Outcomes in Adults. Ann Behav Med (2016) 0.75
Primary care weight loss maintenance with behavioral nutrition: An observational study. Obesity (Silver Spring) (2015) 0.75
Obesity and kidney disease: Hidden consequences of the epidemic. Indian J Nephrol (2017) 0.75
[Fat people have common cancers]. MMW Fortschr Med (2014) 0.75
Impact of race and tumor subtype on second malignancy risk in women with breast cancer. Springerplus (2016) 0.75
Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor. Diabetes Metab Syndr Obes (2015) 0.75
Aspiration therapy for obesity; a safe and effective treatment. BMC Obes (2016) 0.75
The Association Between Body Size and Breast Cancer in Han Women in Northern and Eastern China. Oncologist (2016) 0.75
Waist-hip Ratio (WHR), a Better Predictor for Prostate Cancer than Body Mass Index (BMI): Results from a Chinese Hospital-based Biopsy Cohort. Sci Rep (2017) 0.75
Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study. BMJ Open (2017) 0.75
Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study. Gynecol Oncol (2017) 0.75
Body Mass Index and Cancer Mortality Among Korean Older Middle-Aged Men: A Prospective Cohort Study. Medicine (Baltimore) (2016) 0.75
The Added Value of Medical Testing in Underwriting Life Insurance. PLoS One (2015) 0.75
Obesity and kidney disease: hidden consequences of the epidemic. Pediatr Nephrol (2017) 0.75
Puberty is an important developmental period for the establishment of adipose tissue mass and metabolic homeostasis. Adipocyte (2017) 0.75
Nutritional approaches for managing obesity-associated metabolic diseases. J Endocrinol (2017) 0.75
Obesity and kidney disease: hidden consequences of the epidemic. Clin Kidney J (2017) 0.75
Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. CA Cancer J Clin (2017) 0.75
Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies. Diabetologia (2016) 0.75
Risk of cardiovascular disease among women with endometrial cancer compared to cancer-free women in the Women's Health Initiative. Cancer Epidemiol (2017) 0.75
Genetically predicted high body mass index was associated with increased gastric cancer risk. Eur J Hum Genet (2017) 0.75
Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status. Eur J Epidemiol (2017) 0.75
Quantifying the genetic correlation between multiple cancer types. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Kidney Dis (Basel) (2017) 0.75
What Is the Evidence for Paediatric/Adolescent Bariatric Surgery? Curr Obes Rep (2017) 0.75
Interaction between obesity and the Hypoxia Inducible Factor 3 Alpha Subunit rs3826795 polymorphism in relation with plasma alanine aminotransferase. BMC Med Genet (2017) 0.75
Prospective evaluation of abnormal glucose metabolism and insulin resistance in patients with atypical endometrial hyperplasia and endometrial cancer. Support Care Cancer (2016) 0.75
Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1. J Cell Mol Med (2017) 0.75
Obesity, adiposopathy, and quantitative imaging biomarkers. Radiol Bras (2017) 0.75
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (2004) 39.54
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet (2012) 20.56
A structural approach to selection bias. Epidemiology (2004) 16.44
Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol (2010) 10.70
Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med (2011) 10.33
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ (2007) 8.00
Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr (2002) 7.01
Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst (2000) 4.39
Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med (2010) 3.41
Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem (2008) 2.40
Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med (2012) 2.22
Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst (2012) 2.13
Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst (2010) 1.99
Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies. Ann Oncol (2012) 1.97
Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study. Cancer Epidemiol (2012) 1.89
Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer (2006) 1.80
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.75
Cancer recording and mortality in the General Practice Research Database and linked cancer registries. Pharmacoepidemiol Drug Saf (2012) 1.62
Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. Pharmacoepidemiol Drug Saf (2004) 1.61
Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD). BMJ Open (2013) 1.57
Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst (2003) 1.55
Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol (2008) 1.45
Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies. Eur J Cancer Prev (2013) 1.44
Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. Am J Epidemiol (2009) 1.40
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res (2012) 1.37
Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Int J Epidemiol (2012) 1.33
Body size and colorectal cancer risk after 16.3 years of follow-up: an analysis from the Netherlands Cohort Study. Am J Epidemiol (2011) 1.20
Body mass index and microsatellite instability in colorectal cancer: a population-based study. Cancer Epidemiol Biomarkers Prev (2013) 1.12
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Gynecol Oncol (2012) 1.11